🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Brazil / NCT07469280
Starting soon Not applicable

High-Intensity Progressive Inspiratory Muscle Training in Class III Obesity and Obstructive Sleep Apnea

NCT07469280 · tracked via the Priya Life Science Brazil tracker
Sponsor
University of the State of Santa Catarina
Phase
Not applicable
Started
2026-05-01
Last updated
2026-03-23

Condition(s) studied

Obesity, Class IIISleep Apnea, ObstructiveInspiratory Muscle Training

Investigational drug(s) / intervention(s)

High-Intensity Progressive Inspiratory Muscle Training (IMT)

High-Intensity Progressive Inspiratory Muscle Training (IMT): "The intervention consists of 12 weeks of inspiratory muscle training performed 5 days per week. Each session includes 30 breaths through a resistive loading device (POWERbreathe). The training intensity starts at 40% of the Maximum Inspiratory Pressure (MIP) and progressively increases to 90% of MIP. Training load is adjusted weekly based on new MIP measurements to ensure high-intensity stimulus. Compliance and adverse events will be monitored through a training diary."

Study summary

The purpose of this study is to evaluate the feasibility and effects of a 12-week high-intensity progressive Inspiratory Muscle Training (IMT) program in individuals with Class III obesity (BMI ≥ 40 kg/m²) and obstructive sleep apnea (OSA). Using a single-case experimental design (SCED) with multiple baselines, the study will investigate whether this respiratory intervention can reduce the severity of sleep apnea, as measured by the Apnea-Hypopnea Index (AHI), and improve inspiratory muscle strength and sleep quality. Participants will perform daily training sessions using a resistive loading device (POWERbreathe), with intensity progressing from 40% to 90% of their maximum inspiratory pressure.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: -Adults (≥18 years). * Of both genders. * Class III obesity (BMI \> 40 kg/m²). * Diagnosis of OSA. * Without neurological conditions that would prevent them from responding to the study assessments. Exclusion Criteria: * Systemic diseases (pulmonary, cardiac or renal). * Are using medications that may affect muscle performance. * Are currently using CPAP therapy. * Conditions that could compromise adherence to the study protocol.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Santa Catarina State University - CEFID (Center of Health and Sport Sciences) Florianópolis Santa Catarina

More University of the State of Santa Catarina trials in Brazil

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07469280 on ClinicalTrials.gov ↗ ← All trials in Brazil